IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Russia

  • ID: 1408494
  • Report
  • Region: Russia
  • 48 Pages
  • IMS Health
1 of 3
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Note: Product cover images may vary from those shown
2 of 3
1. HEALTHCARE SYSTEM
Facts & Figures
Market Indicators
Provision & Funding
Reform Programme
Systemic Failure
New Priorities to 2025
Impact of Sanctions

2. PRICING
Prescription Drugs
Regulatory Bodies
Pricing Regulations
Amendments to Drug Law
DLO Pricing
Regional Schemes
Concerns about Withdrawal of Cheap Essential Drugs
Further Amendments to Pricing Methodology
Generic Drugs
Generics
Biosimilars
Previous Regulations
Hospital Drugs
OTC Drugs

3. REIMBURSEMENT
Admission to Reimbursement
DLO Coverage
Previous Procedure
Other Public Schemes
Proposals for Further Amendments to Procedure
Plans for a Comprehensive National Reimbursement Scheme
Coverage of Rare Diseases
Reimbursement Categories
Reimbursement Prices
Hospital Reimbursement
Formularies
Funding
Changes in Reimbursement Status
EDL
DLO and Other Lists
Changes in Reimbursement Prices
Price Increases for Cheap EDL Products
DLO Prices
Other Schemes

4. PHARMACOECONOMICS
Pharmacoeconomic Requirements
Integrated Analysis
Further Changes
Scientific Advice
Prior Position

5. PRICE BUILD UP
Wholesalers
Margins
Background
Retail Pharmacies
Margins
Background
Dispensing Doctors
Sales Tax

6. COST CONTAINMENT
Industry Paybacks
Promotional Costs
Patient Co-payments
Pharmaceuticals
Healthcare
Prescribing Controls
Treatment Standards
Electronic Platform
Hospital Prescribing
Reform Proposals
Generics
INN Prescribing
Generic Substitution
Tendering
Biosimilars
Compulsory Licensing
Rx-to-OTC Switches
Parallel Trade
Counterfeits

7. FUTURE DEVELOPMENTS
Outlook
Plans for Roll-out of Drug Reimbursement System
Further Amendment to EDL, DLO Procedures
Further Amendments to Pricing Regulations

8. NAMES & ADDRESSES
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll